CSTL
Price
$22.98
Change
-$0.74 (-3.12%)
Updated
Jul 13 closing price
Capitalization
697.29M
16 days until earnings call
Intraday BUY SELL Signals
VCYT
Price
$57.48
Change
+$0.51 (+0.90%)
Updated
Jul 13 closing price
Capitalization
4.59B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSTL vs VCYT

CSTL vs VCYT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CSTL vs. VCYT commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a StrongBuy and VCYT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (CSTL: $22.98 vs. VCYT: $57.48)
Brand notoriety: CSTL and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSTL: 35% vs. VCYT: 38%
Market capitalization -- CSTL: $697.29M vs. VCYT: $4.59B
CSTL [@Medical Specialties] is valued at $697.29M. VCYT’s [@Medical Specialties] market capitalization is $4.59B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $17.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • CSTL’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CSTL and VCYT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 3 bullish TA indicator(s).

  • CSTL’s TA Score: 4 bullish, 5 bearish.
  • VCYT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CSTL is a better buy in the short-term than VCYT.

Price Growth

CSTL (@Medical Specialties) experienced а -5.08% price change this week, while VCYT (@Medical Specialties) price change was -0.89% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.19%. For the same industry, the average monthly price growth was +9.26%, and the average quarterly price growth was +1.11%.

Reported Earning Dates

CSTL is expected to report earnings on Jul 30, 2026.

VCYT is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Medical Specialties (-3.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($4.59B) has a higher market cap than CSTL($697M). VCYT has higher P/E ratio than CSTL: VCYT (53.22) vs CSTL (30.24). VCYT YTD gains are higher at: 36.532 vs. CSTL (-40.925). VCYT has higher annual earnings (EBITDA): 112M vs. CSTL (-2.52M). VCYT has more cash in the bank: 439M vs. CSTL (262M). CSTL has less debt than VCYT: CSTL (36.7M) vs VCYT (39.3M). VCYT has higher revenues than CSTL: VCYT (542M) vs CSTL (340M).
CSTLVCYTCSTL / VCYT
Capitalization697M4.59B15%
EBITDA-2.52M112M-2%
Gain YTD-40.92536.532-112%
P/E Ratio30.2453.2257%
Revenue340M542M63%
Total Cash262M439M60%
Total Debt36.7M39.3M93%
FUNDAMENTALS RATINGS
CSTL vs VCYT: Fundamental Ratings
CSTL
VCYT
OUTLOOK RATING
1..100
3382
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
9381
PRICE GROWTH RATING
1..100
5336
P/E GROWTH RATING
1..100
9968
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSTL's Valuation (48) in the null industry is in the same range as VCYT (64) in the Biotechnology industry. This means that CSTL’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as CSTL (100) in the null industry. This means that VCYT’s stock grew similarly to CSTL’s over the last 12 months.

VCYT's SMR Rating (81) in the Biotechnology industry is in the same range as CSTL (93) in the null industry. This means that VCYT’s stock grew similarly to CSTL’s over the last 12 months.

VCYT's Price Growth Rating (36) in the Biotechnology industry is in the same range as CSTL (53) in the null industry. This means that VCYT’s stock grew similarly to CSTL’s over the last 12 months.

VCYT's P/E Growth Rating (68) in the Biotechnology industry is in the same range as CSTL (99) in the null industry. This means that VCYT’s stock grew similarly to CSTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSTLVCYT
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
66%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
Bullish Trend 18 days ago
73%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CSTL
Daily Signal:
Gain/Loss:
VCYT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIBCX55.95N/A
N/A
Hartford Capital Appreciation HLS IB
CPOCX18.82N/A
N/A
Morgan Stanley Insight L
EQIRX18.08N/A
N/A
Allspring Emerging Markets Eq Advtg R6
PRUFX112.35N/A
N/A
T. Rowe Price Growth Stock I
MIDKX27.71-0.16
-0.57%
Shelton S&P Midcap Index K